Form D · Pharmaceuticals
CHINA PHARMA HOLDINGS, INC.
Haikou, F4 · CIK 0001106644
Offering snapshot reported Nov 29, 2021 · SEC filing
- Reported sold
- $5.25M Offering amount: $5.25M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 17, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 29, 2021 | Initial | $5,250,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-422728
Source: Form D, filed Nov 29, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gene Michael Bennett | Director |
| Baowen Dong | Director |
| Zhilin Li | Director, Executive |
| Heung Mei Tsui | Director |
| Yingwen Zhang | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
Second Floor, No. 17, Jinpan Road
Haikou, F4, 570216
Haikou, F4, 570216